Skip to main content

Biotechnology in Europe and Latin America

Prospects for Co-operation

  • Book
  • © 1989

Overview

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (21 chapters)

  1. Biotechnology in Latin America

  2. Health in the Third World: The Role of International Co-operation

  3. Conclusions and Analysis

Keywords

About this book

The accession of Spain and Portugal to membership of the European Community in January 1985 not only brought new vitality to the European initiative, but served as a powerful reminder of the broader dimensions of the Spanish- and Portuguese-speaking worlds. A reinforcement of Europe's natural and historical interna­ tionalism of outlook was particularly relevant in the context of biotechnology; for the sophisticated multi-disciplinary scientific base, and the several broad application areas, force on biotechnol­ ogy an internationalism both for access to scientific capability, and for access to worldwide markets. Such was the rationale for 'SOBELA': a 'Seminar on Biotechnol­ ogy in Europe and Latin America', which in April 1987 brought some 50 Latin American entrepreneurs, policy-makers and academic leaders to Europe and to Brussels. At the Commission's Borschette Conference Centre, they heard presentations from eleven of the Community Member States, each emphasising its strengths in bio­ technology and its interest in promoting industrial collaboration with firms in Latin America. The seminar was opened by speeches from Vice-President Karl­ Heinz Narjes on behalf of the Commission, and by His Excellency Luis Ramiro Alfonsin of Argentina, senior Latin American diplomat in Brussels. In the closing session, Directors-General Paolo Fasella (Science, Research and Development, DG XII) and Jean Durieux (External Relations, DG I) welcomed Their Excellencies the ambas­ sadors from Argentina, Mexico, Brazil, Uruguay and Colombia.

Editors and Affiliations

  • Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

    Bernardo Sorj

  • Concertation Unit for Biotechnology in Europe, CUBE, Commission of the European Communities, Brussels, Belgium

    Mark Cantley

  • Bénézech-Simpson & Co., European Biotechnology Consultancy, Slough, UK

    Karl Simpson

Bibliographic Information

Publish with us